ALFACELL CORP
S-1, EX-23.1, 2000-05-31
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: ALFACELL CORP, S-1, 2000-05-31
Next: VALLEY NATIONAL BANCORP, 8-K, 2000-05-31



                                                                    EXHIBIT 23.1


                          INDEPENDENT AUDITOR'S CONSENT


The Board of Directors
Alfacell Corporation

     We consent to the use of our report included herein and to the reference to
our firm  under the  heading  "Experts"  in the  prospectus.  Our  report  dated
November 2, 1999 contains an explanatory  paragraph that states that the Company
has suffered  recurring losses from operations and has limited liquid resources,
which raise  substantial doubt about its ability to continue as a going concern.
The financial  statements do not include any adjustments  that might result from
the outcome of that uncertainty.

                                                  /s/ KPMG LLP



Short Hills, New Jersey
May 30, 2000



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission